S&P 500   3,388.90 (+0.55%)
DOW   29,366.60 (+0.46%)
QQQ   237.01 (+0.97%)
AAPL   323.97 (+1.56%)
FB   217.46 (-0.16%)
MSFT   187.06 (-0.09%)
GOOGL   1,528.38 (+0.59%)
AMZN   2,180.90 (+1.17%)
CGC   21.90 (-0.23%)
NVDA   311.31 (+4.97%)
BABA   221.83 (+0.59%)
MU   59.12 (+2.37%)
GE   12.88 (+1.02%)
TSLA   938.64 (+9.35%)
AMD   59.06 (+3.80%)
T   38.43 (+0.44%)
ACB   1.71 (+4.28%)
NFLX   387.70 (-0.02%)
BAC   34.72 (+1.31%)
DIS   140.91 (+1.27%)
GILD   66.91 (-0.16%)
S&P 500   3,388.90 (+0.55%)
DOW   29,366.60 (+0.46%)
QQQ   237.01 (+0.97%)
AAPL   323.97 (+1.56%)
FB   217.46 (-0.16%)
MSFT   187.06 (-0.09%)
GOOGL   1,528.38 (+0.59%)
AMZN   2,180.90 (+1.17%)
CGC   21.90 (-0.23%)
NVDA   311.31 (+4.97%)
BABA   221.83 (+0.59%)
MU   59.12 (+2.37%)
GE   12.88 (+1.02%)
TSLA   938.64 (+9.35%)
AMD   59.06 (+3.80%)
T   38.43 (+0.44%)
ACB   1.71 (+4.28%)
NFLX   387.70 (-0.02%)
BAC   34.72 (+1.31%)
DIS   140.91 (+1.27%)
GILD   66.91 (-0.16%)
S&P 500   3,388.90 (+0.55%)
DOW   29,366.60 (+0.46%)
QQQ   237.01 (+0.97%)
AAPL   323.97 (+1.56%)
FB   217.46 (-0.16%)
MSFT   187.06 (-0.09%)
GOOGL   1,528.38 (+0.59%)
AMZN   2,180.90 (+1.17%)
CGC   21.90 (-0.23%)
NVDA   311.31 (+4.97%)
BABA   221.83 (+0.59%)
MU   59.12 (+2.37%)
GE   12.88 (+1.02%)
TSLA   938.64 (+9.35%)
AMD   59.06 (+3.80%)
T   38.43 (+0.44%)
ACB   1.71 (+4.28%)
NFLX   387.70 (-0.02%)
BAC   34.72 (+1.31%)
DIS   140.91 (+1.27%)
GILD   66.91 (-0.16%)
S&P 500   3,388.90 (+0.55%)
DOW   29,366.60 (+0.46%)
QQQ   237.01 (+0.97%)
AAPL   323.97 (+1.56%)
FB   217.46 (-0.16%)
MSFT   187.06 (-0.09%)
GOOGL   1,528.38 (+0.59%)
AMZN   2,180.90 (+1.17%)
CGC   21.90 (-0.23%)
NVDA   311.31 (+4.97%)
BABA   221.83 (+0.59%)
MU   59.12 (+2.37%)
GE   12.88 (+1.02%)
TSLA   938.64 (+9.35%)
AMD   59.06 (+3.80%)
T   38.43 (+0.44%)
ACB   1.71 (+4.28%)
NFLX   387.70 (-0.02%)
BAC   34.72 (+1.31%)
DIS   140.91 (+1.27%)
GILD   66.91 (-0.16%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Intercept PharmaceuticalsGW Pharmaceuticals PLC-EvotecUltragenyx PharmaceuticalMirati Therapeutics
SymbolNASDAQ:ICPTNASDAQ:GWPHOTCMKTS:EVTCYNASDAQ:RARENASDAQ:MRTX
Price Information
Current Price$95.38$125.04$56.01$60.93$97.88
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$150.11$204.36N/A$75.09$107.93
% Upside from Price Target57.38% upside63.44% upsideN/A23.24% upside10.27% upside
Trade Information
Market Cap$3.23 billion$3.93 billion$4.26 billion$3.54 billion$3.88 billion
Beta1.742.191.22.352.31
Average Volume461,346482,051257402,517387,559
Sales & Book Value
Annual Revenue$179.80 million$12.74 million$443.55 million$103.71 million$12.93 million
Price / Sales17.36303.189.5334.01298.56
CashflowN/AN/A$1.82 per shareN/AN/A
Price / CashN/AN/A30.82N/AN/A
Book Value$0.64 per shareN/A$6.73 per share$12.04 per share$5.86 per share
Price / Book149.03∞8.325.0616.70
Profitability
Net Income$-309,240,000.00$-79,880,000.00$99.41 million$-402,730,000.00$-98,420,000.00
EPS($10.86)($10.56)$1.32($7.36)($3.19)
Trailing P/E RatioN/AN/A68.30N/AN/A
Forward P/E RatioN/A121.40∞N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-143.09%-26.80%12.91%-388.30%-2,698.66%
Return on Equity (ROE)-495.47%-23.04%12.32%-49.81%-48.60%
Return on Assets (ROA)-51.42%-19.72%5.76%-42.59%-44.81%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio4.02%0.03%0.91%0.04%N/A
Current Ratio5.49%7.33%3.06%6.79%13.15%
Quick Ratio5.49%6.60%2.97%6.64%13.15%
Ownership Information
Institutional Ownership Percentage78.10%84.35%N/A97.75%N/A
Insider Ownership Percentage5.00%3.60%N/A7.80%4.70%
Miscellaneous
Employees4837912,617N/A63
Shares Outstanding32.73 million30.89 million75.45 million57.89 million39.44 million
Next Earnings Date2/25/2020 (Confirmed)2/25/2020 (Confirmed)3/17/2020 (Estimated)5/4/2020 (Estimated)2/27/2020 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel